Related Experiment Videos
Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines
S B Jakowlew1, A Mathias, P Chung
1National Cancer Institute, Biomarkers and Prevention Research Branch, Rockville, Maryland 20850, USA.
Abstract:
Specific cDNA probes for transforming growth factor beta s (TGF-beta s) 1, 2, and 3 and TGF-beta types I, II, and III receptors were used to study expression of the mRNAs of the different TGF-beta ligand and TGF-beta receptor isoforms in cultured non-small cell lung cancer (NSCLC) cells and small cell lung cancer (SCLC) cells. Expression of TGF-beta 1 mRNA was detected in both cell types using Northern blot hybridization, with the level of expression of this mRNA being higher in several NSCLC cell lines. In addition, expression of TGF-beta 2 and TGF-beta 3 mRNAs was also detected in NSCLC and SCLC cells but at levels that were lower than that of TGF-beta 1 mRNA. Besides expression of a 3.4-kilobase (kb) TGF-beta 3 transcript, a smaller 2.8-kb TGF-beta 3 transcript was detected in some NSCLC and SCLC cells. TGF-beta 1 and TGF-beta 2 proteins were detected in the conditioned media of NSCLC and SCLC cells, with the levels being higher in several NSCLC cells than in SCLC cells. Expression of TGF-beta types I and II receptor mRNAs was also detected in most NSCLC and SCLC cells, with expression of a 5.5-kb type I receptor mRNA being higher than that of a 5.5-kb type II receptor mRNA in both cell types. In contrast, a 6-kb TGF-beta type III receptor mRNA was detected in only some NSCLC cells and could not be detected in the SCLC cells examined. Also, there was an inverse relationship between the level of expression of the 5.5-kb TGF-beta type I receptor mRNA and that of the 6-kb TGF-beta type III receptor mRNA. Addition of TGF-beta 1 and TGF-beta 2 proteins resulted in an increase in the mRNAs for TGF-beta s 1 and 2 and an increase in the amount of TGF-beta 1 protein in some NSCLC cells, indicating that these cells are responsive to TGF-beta and its effects. At the same time, a differential change in expression of the 2.8- and 3.4-kb TGF-beta 3 transcripts was detected in some lung cancer cells following the addition of TGF-beta 1 and TGF-beta 2. Also, addition of TGF-beta 1 to NSCLC cells inhibited colony formation of some of these cells in soft agarose in a dose-dependent manner.(ABSTRACT TRUNCATED AT 400 WORDS)
Insights
This study investigated transforming growth factor beta (TGF-beta) signaling in lung cancer cells. Researchers found TGF-beta 1, 2, and 3, along with their receptors, are expressed in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells, with TGF-beta 1 being most prevalent.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Transforming growth factor beta (TGF-beta) signaling plays a crucial role in cell growth, differentiation, and apoptosis.
- Dysregulation of TGF-beta signaling is implicated in the development and progression of various cancers, including lung cancer.
- Understanding TGF-beta ligand and receptor expression in different lung cancer subtypes is essential for targeted therapies.
Purpose of the Study:
- To investigate the expression profiles of TGF-beta ligands (1, 2, and 3) and their receptors (types I, II, and III) in cultured non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells.
- To determine the functional response of lung cancer cells to TGF-beta stimulation.
- To explore the potential role of TGF-beta signaling in inhibiting lung cancer cell proliferation.
Main Methods:
- Utilized specific cDNA probes for Northern blot hybridization to detect mRNA expression of TGF-beta isoforms and their receptors in NSCLC and SCLC cell lines.
- Analyzed TGF-beta protein levels in conditioned media.
- Administered TGF-beta 1 and TGF-beta 2 to cell cultures to assess cellular responses and effects on gene expression and colony formation.
Main Results:
- TGF-beta 1 mRNA was detected in both NSCLC and SCLC cells, with higher expression in NSCLC.
- TGF-beta 1 and 2 proteins were found in conditioned media, again at higher levels in NSCLC cells.
- TGF-beta type I and II receptor mRNAs were widely expressed, while type III receptor mRNA was detected only in some NSCLC cells. TGF-beta 1 addition inhibited colony formation in some NSCLC cells.
Conclusions:
- Lung cancer cells (NSCLC and SCLC) express various TGF-beta ligands and receptors, suggesting active signaling pathways.
- TGF-beta 1 appears to be a significant mediator in NSCLC, with potential inhibitory effects on cell proliferation.
- The differential expression of TGF-beta receptors and the response to TGF-beta stimulation highlight the complexity of TGF-beta signaling in lung cancer and its therapeutic potential.